chr10-133555402-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001143764.3(SYCE1):āc.867C>Gā(p.Val289Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00476 in 1,614,108 control chromosomes in the GnomAD database, including 44 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0036 ( 4 hom., cov: 33)
Exomes š: 0.0049 ( 40 hom. )
Consequence
SYCE1
NM_001143764.3 synonymous
NM_001143764.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.249
Genes affected
SYCE1 (HGNC:28852): (synaptonemal complex central element protein 1) This gene encodes a member of the synaptonemal complex, which links homologous chromosomes during prophase I of meiosis. The tripartite structure of the complex is highly conserved amongst metazoans. It consists of two lateral elements and a central region formed by transverse elements and a central element. The protein encoded by this gene localizes to the central element and is required for initiation and elongation of the synapsis. Allelic variants of this gene have been associated with premature ovarian failure and spermatogenic failure. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
CYP2E1 (HGNC:2631): (cytochrome P450 family 2 subfamily E member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is induced by ethanol, the diabetic state, and starvation. The enzyme metabolizes both endogenous substrates, such as ethanol, acetone, and acetal, as well as exogenous substrates including benzene, carbon tetrachloride, ethylene glycol, and nitrosamines which are premutagens found in cigarette smoke. Due to its many substrates, this enzyme may be involved in such varied processes as gluconeogenesis, hepatic cirrhosis, diabetes, and cancer. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 10-133555402-G-C is Benign according to our data. Variant chr10-133555402-G-C is described in ClinVar as [Benign]. Clinvar id is 711322.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-133555402-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.249 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SYCE1 | NM_001143764.3 | c.867C>G | p.Val289Val | synonymous_variant | 12/13 | ENST00000343131.7 | NP_001137236.1 | |
SYCE1 | NM_001143763.2 | c.867C>G | p.Val289Val | synonymous_variant | 12/13 | NP_001137235.1 | ||
SYCE1 | NM_130784.4 | c.759C>G | p.Val253Val | synonymous_variant | 12/13 | NP_570140.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00357 AC: 543AN: 152194Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
543
AN:
152194
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00402 AC: 1011AN: 251452Hom.: 10 AF XY: 0.00442 AC XY: 601AN XY: 135896
GnomAD3 exomes
AF:
AC:
1011
AN:
251452
Hom.:
AF XY:
AC XY:
601
AN XY:
135896
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00488 AC: 7133AN: 1461796Hom.: 40 Cov.: 33 AF XY: 0.00497 AC XY: 3617AN XY: 727202
GnomAD4 exome
AF:
AC:
7133
AN:
1461796
Hom.:
Cov.:
33
AF XY:
AC XY:
3617
AN XY:
727202
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00357 AC: 543AN: 152312Hom.: 4 Cov.: 33 AF XY: 0.00357 AC XY: 266AN XY: 74466
GnomAD4 genome
AF:
AC:
543
AN:
152312
Hom.:
Cov.:
33
AF XY:
AC XY:
266
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
26
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at